- Forums
- ASX - By Stock
- SGR
- Ann: Appendix 4D & 2023 Half-Year Financial Report
Ann: Appendix 4D & 2023 Half-Year Financial Report, page-39
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SGR (ASX) to my watchlist
|
|||||
Last
49.3¢ |
Change
-0.013(2.48%) |
Mkt cap ! $1.412B |
Open | High | Low | Value | Volume |
50.0¢ | 50.5¢ | 49.0¢ | $1.076M | 2.174M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 1355307 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 236444 | 28 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
64 | 1355307 | 0.490 |
29 | 921999 | 0.485 |
54 | 1302493 | 0.480 |
25 | 1696196 | 0.475 |
27 | 831077 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.495 | 236356 | 28 |
0.500 | 744243 | 35 |
0.505 | 621660 | 17 |
0.510 | 879356 | 25 |
0.515 | 750925 | 21 |
Last trade - 11.56am 16/07/2024 (20 minute delay) ? |
Featured News
SGR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online